Tablet: Adults and children ≥12 years: 1 tab or 1 teaspoonful every 4-6 hrs, not more than 6 tabs/day.
Children 6-12 years: ½ tab or ½ teaspoonful every 4-6 hrs, not more than 3 tabs/day; 2-6 years: ¼ tab or ¼ teaspoonful every 4-6 hrs, not more than 1.5 tab/day.
Syrup: Adults and children ≥12 years: 1 teaspoonful every 4-6 hrs, not more than 6 teaspoonful/day.
Children 6-12 years: ½ teaspoonful every 4-6 hrs, not more than 3 teaspoonful/day; 2-6 years: ¼ teaspoonful every 4-6 hrs, not more than 1.5 teaspoonful/day.
For infants and children, dose will be more accurate when based on response and degree of illness rather than age, weight or area of body surface. Drug should be administered simultaneously with food or milk to alleviate gastrointestinal side effects.
Dose depends on patients' condition and response, when appropriate reaction is reached, dose should be tapered off until the lowest dose, giving sufficient permanent clinical response.
Administration should be stopped as soon as possible. Patients should always be monitored toward signs of the need of dose-adjustment, as severity of illness or stress (surgery, infection, trauma).
In long-term therapy, administration should be gradually reduced. Before long-term therapy, patients should first undergo ECG, blood pressure, chest and spinal radiography, sugar test and HPA axis function, as well as gastrointestinal radiography for patients who are susceptible to gastrointestinal disturbance. During long-term therapy, periodic evaluation should be done on height, weight of chest and spinal radiography, hematopoietic, electrolyte, glucose tolerance, blood pressure and ocular pressure.